etravirine (Intelence)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor

Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."

Approved adult dosing

two 100 mg tablets, twice a day after meals

• Morning

Intelence

• Evening

Intelence

Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.

Notes on taking this medication

• Take after a meal (do not take without food)
• Intelence can interact with other drugs; consult your medical provider

Side effects

• Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
• Nausea
• Intelence has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

SOURCE: United States Department of Veterans Affairs. "Drug Dosing Toolkit, Intelence (etravirine)."
<http://www.hiv.va.gov/vahiv?page=treat-drug-Intelence>

Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? Use the pill identifier tool on RxList.